Navigation Links
Weaver Popcorn Company Issues a Nationwide Precautionary Voluntary Recall of 12 oz. (340g) Trail's End(R) Chocolatey Peanut Clusters
Date:3/13/2009

INDIANAPOLIS, March 13 /PRNewswire/ -- As a result of the FDA expanding the Peanut Corporation of America's (PCA) Salmonella related recall to include all peanut ingredient products produced in PCA's Plainview, Texas facility since January 1, 2007, Weaver Popcorn Company, Inc. has issued a precautionary voluntary recall for the following product:

-- 12 oz. (340g) bags of Trail's End(R) Chocolatey Peanut Clusters, with Best Before code dates

031308, 040408, 040508, 052108, 053008, 053108, 061408, 062208, 070108, 071608, 071808, 071908, 082508, 082708, 082808, 082908, 083008, 090908, 091208, 091308, 091508, 091608, 091708, 091808, 091908, 092008, 092208, 092308, 092408, 092508, 093008, 100108, 100208, 100608, 100708, 100808, 100908, 101008, 101308, 101508, 101608, 102008, 102108, 102208, 102308, 102408, 102508, 102708, 102808, 102908, 103108, 110308, 110508, 110608, 111708, 111808, 111908, 112208, 112408, 112508, 112608, 042509, 051509, 051809, 051909, 052009, 052609, 052709, 061309, 061609, 061909, 062009, 062209, 062309, 062409, 062509, 062909, 070209, 070409, 070909, 071109, 071409, 072009, 072209, 072309, 072409 and 073109.

The 12 oz. (340g) Trail's End Chocolatey Peanut Clusters is one of five separately packaged products included in our Trail's End(R) Chocolate Lovers Tin package. The remaining four separately packaged products are not subject to any recall.

"Although we have not received a single health related complaint or any reports of illness related to this product, we are taking this voluntary precautionary action out of an abundance of caution and consistent with our 80-year unwavering commitment to consumer safety and to providing the highest-quality products," said Mike Weaver, Weaver Popcorn Company President and CEO.

Since the vast majority of this product has not been sold for a number of months, it is assumed that what has been sold has been consumed. Consumers who have open bags of this product are urged to destroy it. Consumers with an unopened Trail's End 12 oz. (340g) Chocolatey Peanut Clusters foil bag, with the above listed code dates, can arrange for a refund by calling

1-800-782-4255 (Monday through Friday from 8:00am - 3:00pm EDT).

*** Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. In rare cases, infection with salmonella can result in the organism getting into the bloodstream and producing more severe illnesses, such as arterial infections (i.e. infected aneurysms), endocarditis and arthritis. For more information on Salmonella, please visit the Centers for Disease Control and Prevention's Website at http://www.cdc.gov.


'/>"/>
SOURCE Weaver Popcorn Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
2. Scientists ID Likely Culprit in Popcorn Lung
3. Chemical culprit in popcorn workers lung identified
4. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
5. The Female Health Company to Expand Manufacturing Capacity for FC2 Female Condom By 150%
6. IPC The Hospitalist Company Presents IPC Hospitalist of the Year Award to Tim Osonma, M.D.
7. MAP Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
8. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
9. NuVasive to Present at Cowen and Company 29th Annual Healthcare Conference
10. The Female Health Company Schedules Conference Call to Discuss FDA Approval of FC2 Female Condom(R) for March 12, 2009
11. Female Health Company Receives FDA Approval for FC2 Female Condom(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: